OrthoCellix is developing NeoCart as an autologous cartilage implant using patient cells to repair knee articular cartilage defects.

The center will offer access to treatment for conditions such as rotator cuff repair, ACL recon, knee and hip replacements and foot & ankle/hand & wrist procedures.

NanoHive is exploring the development of a Hive™ Soft Titanium® Spinal Interbody “Smart Implant” with data collection and bone stimulation capability.

Sale proceeds will accelerate investment in portfolio innovation and commercial expansion for spine.

APEX will leverage Bioventus’ sales infrastructure to offer the XCELL PRP system to orthopedics and sports medicine providers.

Global orthopedic revenue reached $62 billion in 2024, with a projected climb to $73 billion by 2028.

Vizient launched a first-of-its-kind sourcing program that targets ASCs. The initiative serves as an example of the evolving opportunities the ASC market will open for industry in the years ahead.

All metal MedCAD products, including AccuPlate plates and AccuShape Ti cranioplasty products, will now be fully converted to 3D titanium printing technology only.

The companies entered an agreement to codevelop and market Gel-One hyaluronate injection for the treatment of osteoarthritis in Japan.

Lovell Government Services will serve as NovApproach Spine’s Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor.